These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18212784)

  • 1. Should we be using calcium-containing phosphate binders in patients on dialysis?
    Spiegel DM; Block GA
    Nat Clin Pract Nephrol; 2008 Mar; 4(3):118-9. PubMed ID: 18212784
    [No Abstract]   [Full Text] [Related]  

  • 2. The demise of calcium-based phosphate binders.
    Ortiz A; Sanchez-Niño MD
    Lancet; 2013 Oct; 382(9900):1232-4. PubMed ID: 23870814
    [No Abstract]   [Full Text] [Related]  

  • 3. ACP Journal Club. Review: non-calcium-based phosphate binders reduce mortality compared with calcium-based binders in CKD.
    Parikh CR
    Ann Intern Med; 2013 Nov; 159(10):JC2. PubMed ID: 24247692
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of calcium acetate with calcium carbonate as phosphate binder in patients on maintenance haemodialysis.
    Saif I; Halim A; Altaf A; Saif M; Khalid M; Ahmad D; Imran H
    J Ayub Med Coll Abbottabad; 2007; 19(4):26-8. PubMed ID: 18693591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-based phosphate binders and chronic kidney disease.
    Hiremath S; Akbari A
    Lancet; 2014 Jan; 383(9913):216. PubMed ID: 24439735
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence of comparative effectiveness without evidence of effectiveness: the case of phosphate binders in CKD.
    Uhlig K
    Am J Kidney Dis; 2014 Jan; 63(1):13-5. PubMed ID: 24200463
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.
    Jamal SA; Vandermeer B; Raggi P; Mendelssohn DC; Chatterley T; Dorgan M; Lok CE; Fitchett D; Tsuyuki RT
    Lancet; 2013 Oct; 382(9900):1268-77. PubMed ID: 23870817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphate binders. Is selection determined by price?: Yes.
    de Francisco AL
    Nefrologia; 2012; 32(2):235-9. PubMed ID: 22466264
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of the aluminum phosphate-binders in hemodialysis in the ultrapure water era].
    Arenas MD; Malek T; Gil MT; Moledous A; Núñez C; Alvarez-Ude F
    Nefrologia; 2008; 28(2):168-73. PubMed ID: 18454706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial.
    Suki WN;
    J Ren Nutr; 2008 Jan; 18(1):91-8. PubMed ID: 18089452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphate binders in CKD: bad news or good news?
    Drüeke TB; Massy ZA
    J Am Soc Nephrol; 2012 Aug; 23(8):1277-80. PubMed ID: 22797178
    [No Abstract]   [Full Text] [Related]  

  • 13. Dietitian-led education program to improve phosphate control in a single-center hemodialysis population.
    Reddy V; Symes F; Sethi N; Scally AJ; Scott J; Mumtaz R; Stoves J
    J Ren Nutr; 2009 Jul; 19(4):314-20. PubMed ID: 19539185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperphosphatemia in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
    Bleyer AJ
    Am J Kidney Dis; 2008 Nov; 52(5):1024; author reply 1025. PubMed ID: 18971019
    [No Abstract]   [Full Text] [Related]  

  • 15. Sevelamer versus calcium-based phosphate binders for chronic kidney disease.
    Bravo-Soto GA; Madrid T
    Medwave; 2017 May; 17(Suppl2):e6942. PubMed ID: 28525528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When is Vitamin D contraindicated in dialysis patients?
    Lewin E; Olgaard K
    Semin Dial; 2009; 22(3):240-2. PubMed ID: 19572998
    [No Abstract]   [Full Text] [Related]  

  • 17. When is Vitamin D contraindicated in dialysis patients?
    Brown HJ; Cunningham J
    Semin Dial; 2009; 22(3):237-40. PubMed ID: 19572997
    [No Abstract]   [Full Text] [Related]  

  • 18. Can omeprazole reduce the incidence of hypercalcemia in dialysis patients using calcium containing phosphate binders?
    Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
    J Nephrol; 2010; 23(4):438-43. PubMed ID: 20349423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sevelamer prescriptions after reporting of the Dialysis Clinical Outcomes Revisited (DCOR) trial findings: An analysis of 5,495 patients receiving maintenance dialysis in Ontario, Canada.
    Weir MA; Jain AK; Gomes T; Juurlink DN; Mamdani M; Li L; Garg AX
    Am J Kidney Dis; 2011 Feb; 57(2):357-9. PubMed ID: 21251552
    [No Abstract]   [Full Text] [Related]  

  • 20. Study probes best choice of drug to reduce phosphate in patients on dialysis.
    Mitka M
    JAMA; 2007 Nov; 298(17):1995-6. PubMed ID: 17986688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.